EPISODE · Jul 5, 2022 · 55 MIN
Episode 89: Pharmacovigilance and Adherence to Oral Oncolytics
from Healthcare Unfiltered · host Chadi Nabhan
Joining Chadi on today’s show is Donald Harvey, PharmD, BCOP, FCCP, FHOPA, Winship Cancer Institute of Emory University. Dr. Harvey shares available career paths and how the pharmacist role has evolved over the years, how pharmacists continue to stay involved with patients after discharge, strategies he uses to help cancer patients adhere to oral oncolytics, and his “Call to Action” to improve such adherence – as co-planned by the FDA and ASCO and published in Journal of Clinical Oncology. The discussion is very detailed and enlightening; you won’t want to miss it!View Dr. Harvey’s publication “Call to Action for Improving Oral Anticancer Agent Adherence.”https://ascopubs.org/doi/10.1200/JCO.21.02529Check out Chadi’s website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/Watch all Healthcare Unfiltered episodes on Youtube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA
Embed this episode
What this episode covers
Joining Chadi on today’s show is Donald Harvey, PharmD, BCOP, FCCP, FHOPA, Winship Cancer Institute of Emory University. Dr. Harvey shares available career paths and how the pharmacist role has evolved over the years, how pharmacists continue to stay involved with patients after discharge, strategies he uses to help cancer patients adhere to oral oncolytics, and his “Call to Action” to improve such adherence – as co-planned by the FDA and ASCO and published in Journal of Clinical Oncology. Th...
NOW PLAYING
Episode 89: Pharmacovigilance and Adherence to Oral Oncolytics
No transcript for this episode yet
Similar Episodes
No similar episodes found.